Cyclosporine in combination with mycophenolate mofetil versus methotrexate for graft versus host disease prevention in myeloablative HLA‐identical sibling donor allogeneic hematopoietic cell transplantation

Publisher： John Wiley & Sons Inc

E-ISSN： 1096-8652|90|2|144-148

ISSN： 0361-8609

Source： AMERICAN JOURNAL OF HEMATOLOGY, Vol.90, Iss.2, 2015-02, pp. : 144-148

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Mycophenolate‐based graft versus host disease prophylaxis is not inferior to methotrexate in myeloablative‐related donor stem cell transplantation

By  

AMERICAN JOURNAL OF HEMATOLOGY, Vol. 90, Iss. 5, 2015-05 ,pp. : 392-399

John Wiley & Sons Inc

Access to resources Recommend Favorite

Mycophenolate mofetil for treatment of steroid‐refractory acute graft‐versus‐host disease after pediatric hematopoietic stem cell transplantation

By  

PEDIATRIC TRANSPLANTATION, Vol. 19, Iss. 6, 2015-09 ,pp. : 652-658

John Wiley & Sons Inc

Access to resources Recommend Favorite

RANTES Polymorphisms and the Risk of Graft-versus-Host Disease in Human Leukocyte Antigen-Matched Sibling Allogeneic Hematopoietic Stem Cell Transplantation

By  

Acta Haematologica, Vol. 129, Iss. 3, 2012-11 ,pp. : 137-145

Karger

Access to resources Recommend Favorite

T-Cell Chimerism Is Valuable in Predicting Early Mortality in Steroid-Resistant Acute Graft-versus-Host Disease after Myeloablative Allogeneic Cell Transplantation

By  

Acta Haematologica, Vol. 132, Iss. 2, 2014-03 ,pp. : 187-192

Karger

Access to resources Recommend Favorite

Experience with anidulafungin in patients with allogeneic hematopoietic stem cell transplantation and graft‐versus‐host disease

By  

TRANSPLANT INFECTIOUS DISEASE (ELECTRONIC), Vol. 1398-2273, Iss. 5, 2015-10 ,pp. : 761-767

John Wiley & Sons Inc

Access to resources Recommend Favorite